Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Content Filter
Choose a Topic
Agreement
Appointment
Big Data
Biosimilars
Business
Capacity Expansion
CDMO
Cell and Gene Therapy
Clinical Trials
Collaboration
Continuous Manufacturing
CRISPR
CRO
DNA
Drug Delivery
Drug Development
Drug Discovery
Engineering
Equipment
Excipients
Facility
Formulation
Generics
Healthcare
Immunotherapy
Innovation
Investment
Licensing
Logistics
Manufacturing
Market Expansion
Market Intelligence
Market Prediction
Oncology
Oral Solid Dosage
Orphan Drugs
Packaging
Parenterals
Preclinical
Process Development
Regulatory
Research
Serialization
Stem Cells
Strategic Partnership
Supply Chain
Vaccine
Intermediates
×
Choose a Section
Features
News
Press Releases
Roundtable
In Conversation
Nice Consulting
Virtual Panel
Trends Trending
×
Choose an Issue
Issue Q3 2022
Issue Q2 2022
Issue Q1 2022
Issue Q4 2020
Issue Q3 2020
Issue Q2 2020
Issue Q1 2020
Issue Q4 2019
Issue Q3 2019
Issue Q2 2019
Issue Q1 2019
Issue Q4 2018
Issue Q3 2018
Issue Q2 2018
Issue Q1 2018
Issue Q4 2017
Issue Q3 2017
Issue Q2 2017
Issue Q1 2017
Issue Q4 2016
Issue Q3 2016
Issue Q2 2016
Issue Q1 2016
Issue Q4 2015
×
5840 Articles Available
3
244
Can't find what you're looking for? Try our
advanced search
.
Chromatography
Navigating HPLC Method Development: Tips for Success
PAO-12-23-CL-09
Drug Development
Podcast: Insights from CDO Experts from Samsung Biologics
POD-01-24-CL-01
CDMO
Maximizing Outsourcing Benefits for Virtual Pharma Companies
PAO-09-23-CL-08
Downstream Processing
Technological Innovations Enhancing Downstream Productivity and Their Critical Process Parameters for Real-Time Control
PAO-12-23-CL-07
Roundtable
What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?
PAO-12-23-RT-02
Roundtable
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
PAO-12-23-RT-01
Retinal Disease
Pioneering Breakthroughs in Retinal Disease Treatment
PAO-12-23-CL-01
Glycosylation
S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach
PAO-12-23-CL-06
Cell Therapy Manufacturing
Rethinking Cell Engineering for Cell Therapy Manufacturing
PAO-11-23-CL-03
Sustainable Clinical Trials
Driving a Sustainable Future in Clinical Trials through Decentralized Trial Models
PAO-12-23-CL-05
Process Chemistry
Enabling Client Success with Complementary Services Built upon a Strong Chemistry Foundation
PAO-12-23-CL-02
Supply Chain
Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience
PTV-12-23-CL-02
Stem Cell Therapy
Designing A Recipe for Stem Cell Therapy Success
PTV-12-23-CL-01
Cell and Gene Therapy
Scaling Cell and Gene Therapy Processes from R&D to Production
PAO-12-23-CL-03
CDMO Selection
Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)
PAO-11-23-CL-04
Cell Culture Media
Market Trends Driving the Embrace of Plant-Based Cell-Culture Media Ingredients
PAO-10-23-CL-01
Aqueous Cleaning
The Power of Aqueous Detergents in Critical Cleaning
CDMO
Vetter joins Science Based Targets Initiative
PR-M12-23-01
Viral Vectors
Facing the Dual Scientific and Financial Challenges to Advance Cell and Gene Therapies
PAO-11-23-CL-02
Cell Culture Media
Enabling Controlled End-to-End Biomanufacturing with Animal-Free Culture Media Products
PAO-08-23-CL-05
Antibody-Drug Conjugates
Reducing ADC Development Timelines with Integrated Development and Manufacturing Services
PAO-11-23-CL-01
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
PAO-10-23-CL-07
Partnerships
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
PR-M11-23-01
Biotherapeutics
Leveraging the Tenacity of Biotherapeutics Development Experience to Build a Dynamic CDMO
PAO-10-23-CL-05
«
3
244
»